Reactome: A Curated Pathway Database
THIS SITE IS USED FOR CURATION AND TESTING
IT IS NOT STABLE, IS LINKED TO AN INCOMPLETE DATA SET, AND IS NOT MONITORED FOR PERFORMANCE. WE STRONGLY RECOMMEND THE USE OF OUR PUBLIC SITE

Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Name Email address

Details on Person B-cell lymphoma/leukemia 10 (BCL10) is the downstream signal...

Class:IdSummation:5607603
_displayNameB-cell lymphoma/leukemia 10 (BCL10) is the downstream signal...
_timestamp2014-07-18 10:38:41
created[InstanceEdit:5607612] Garapati, P V, 2014-07-14
literatureReference[LiteratureReference:5607464] CARD9 is a novel caspase recruitment domain-containing protein that interacts with BCL10/CLAP and activates NF-kappa B
modified[InstanceEdit:5609917] Garapati, P V, 2014-07-18
textB-cell lymphoma/leukemia 10 (BCL10) is the downstream signaling partner of CARD9 and it interacts selectively with the CARD activation domain of CARD9. BCL10 functions as an adaptor between the effector IKK complex and the proximal signaling complexes that interact with CARD9 (Bertin et al. 2000).
(summation)[Reaction:5607733] BCL10 binds CARD9 [Homo sapiens]
[Change default viewing format]
No pathways have been reviewed or authored by B-cell lymphoma/leukemia 10 (BCL10) is the downstream signal... (5607603)